GA
Greytown Advisors’s Pfizer PFE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-7,040
| Closed | -$203K | – | 84 |
|
2023
Q4 | $203K | Sell |
7,040
-795
| -10% | -$22.9K | 0.11% | 76 |
|
2023
Q3 | $260K | Sell |
7,835
-6,103
| -44% | -$202K | 0.14% | 65 |
|
2023
Q2 | $511K | Buy |
13,938
+4
| +0% | +$147 | 0.28% | 42 |
|
2023
Q1 | $569K | Sell |
13,934
-1,341
| -9% | -$54.7K | 0.29% | 45 |
|
2022
Q4 | $783K | Sell |
15,275
-1,206
| -7% | -$61.8K | 0.43% | 33 |
|
2022
Q3 | $721K | Sell |
16,481
-4,402
| -21% | -$193K | 0.44% | 39 |
|
2022
Q2 | $1.1M | Sell |
20,883
-5,868
| -22% | -$308K | 0.62% | 26 |
|
2022
Q1 | $1.39M | Sell |
26,751
-6,657
| -20% | -$345K | 0.67% | 27 |
|
2021
Q4 | $1.97M | Sell |
33,408
-3,694
| -10% | -$218K | 0.84% | 22 |
|
2021
Q3 | $1.6M | Buy |
37,102
+2,645
| +8% | +$114K | 0.71% | 24 |
|
2021
Q2 | $1.35M | Buy |
34,457
+8,580
| +33% | +$336K | 0.65% | 24 |
|
2021
Q1 | $938K | Buy |
25,877
+5,838
| +29% | +$212K | 0.46% | 33 |
|
2020
Q4 | $738K | Buy |
20,039
+5,478
| +38% | +$202K | 0.51% | 32 |
|
2020
Q3 | $534K | Buy |
14,561
+7
| +0% | +$257 | 0.44% | 36 |
|
2020
Q2 | $476K | Sell |
14,554
-11,659
| -44% | -$381K | 0.44% | 33 |
|
2020
Q1 | $856K | Buy |
26,213
+2,504
| +11% | +$81.8K | 0.85% | 24 |
|
2019
Q4 | $929K | Sell |
23,709
-259
| -1% | -$10.1K | 0.66% | 35 |
|
2019
Q3 | $861K | Buy |
23,968
+2,096
| +10% | +$75.3K | 0.64% | 37 |
|
2019
Q2 | $947K | Sell |
21,872
-3,909
| -15% | -$169K | 0.68% | 25 |
|
2019
Q1 | $1.1M | Sell |
25,781
-575
| -2% | -$24.4K | 0.79% | 25 |
|
2018
Q4 | $1.15M | Buy |
26,356
+492
| +2% | +$21.5K | 0.83% | 22 |
|
2018
Q3 | $1.14M | Sell |
25,864
-5,227
| -17% | -$230K | 0.75% | 24 |
|
2018
Q2 | $1.13M | Buy |
31,091
+2,089
| +7% | +$75.8K | 0.53% | 29 |
|
2018
Q1 | $1.03M | Buy |
29,002
+2,564
| +10% | +$91K | 0.51% | 39 |
|
2017
Q4 | $958K | Buy |
26,438
+3,028
| +13% | +$110K | 0.49% | 46 |
|
2017
Q3 | $836K | Buy |
23,410
+728
| +3% | +$26K | 0.48% | 42 |
|
2017
Q2 | $762K | Buy |
22,682
+6,837
| +43% | +$230K | 0.62% | 23 |
|
2017
Q1 | $542K | Buy |
15,845
+7,114
| +81% | +$243K | 0.48% | 29 |
|
2016
Q4 | $284K | Buy |
+8,731
| New | +$284K | 0.27% | 56 |
|